JAKARTA: Indonesia will delay the administering of AstraZeneca's COVID-19 vaccine due to reports of blood clots among some recipients in Europe and would await a review from the World Health Organization , its health minister said on Monday .
The European Medicines Agency has said there is no indication that the events were caused by the vaccination, a view echoed Friday by the WHO, while AstraZeneca said on Sunday its review has shown no evidence of an increased risk of blood clots."To be conservative, the food and drug agency delayed implementation of AstraZeneca as it awaits confirmation from the WHO," health minister Budi Gunadi Sadikin told a parliamentary hearing on Monday.Indonesia received 1.
Thailand, which became the first country outside of Europe to delay use of the AstraZeneca shot on Friday, plans to start using the vaccine on Tuesday, officials said, with the prime minister and his Cabinet the first to receive it.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.